South African law

Greencastle Announces Closing of Private Placement

Retrieved on: 
Thursday, January 21, 2021

Each Warrant entitles the holder thereof to acquire one Common Share at an exercise price of C$0.15 at any time on or before January 21, 2024.

Key Points: 
  • Each Warrant entitles the holder thereof to acquire one Common Share at an exercise price of C$0.15 at any time on or before January 21, 2024.
  • The net proceeds from the Offering will be used for general corporate and working capital purposes.
  • Forward-looking statements may be identified by such terms as "believes", "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan".
  • These and other factors should be considered carefully and readers should not place undue reliance on the Company's forward-looking statements.

REPEAT -- Metallica Metals Provides Corporate Update

Retrieved on: 
Thursday, January 21, 2021

In particular, forward-looking information in this press release includes, but is not limited to, statements with respect to the Companys proposed acquisition, exploration program and the expectations for the mining industry.

Key Points: 
  • In particular, forward-looking information in this press release includes, but is not limited to, statements with respect to the Companys proposed acquisition, exploration program and the expectations for the mining industry.
  • Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct.
  • We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation.
  • Readers are cautioned not to place undue reliance on forward-looking information.

Citizens Financial Group Announces Private Exchange Offers for Five Series of Subordinated Notes Open to Certain Investors

Retrieved on: 
Tuesday, January 12, 2021

Citizens obligation to accept any series of Old Notes tendered in the Exchange Offers is subject to the satisfaction or waiver of certain conditions applicable to the Exchange Offer for such series as described in the Offering Memorandum.

Key Points: 
  • Citizens obligation to accept any series of Old Notes tendered in the Exchange Offers is subject to the satisfaction or waiver of certain conditions applicable to the Exchange Offer for such series as described in the Offering Memorandum.
  • Citizens will enter into a registration rights agreement with respect to each series of the New Notes.
  • Global Bondholder Services Corporation will act as the Information Agent and the Exchange Agent for the Exchange Offers.
  • Citizens Financial Group, Inc. is one of the nations oldest and largest financial institutions, with $179.2 billion in assets as of September 30, 2020.

Special Committee of the Board of Directors of Steel Connect, Inc. Retains Financial Advisor and Legal Counsel

Retrieved on: 
Monday, January 11, 2021

The Special Committee will, among other things, consider the Expression of Interest from Steel Holdings to purchase all outstanding shares of the Companys common stock not currently owned by Steel Holdings or its affiliates, and any alternatives thereto.

Key Points: 
  • The Special Committee will, among other things, consider the Expression of Interest from Steel Holdings to purchase all outstanding shares of the Companys common stock not currently owned by Steel Holdings or its affiliates, and any alternatives thereto.
  • The Board cautions that no decision has yet been made with respect to the Company's response to the Expression of Interest or any alternatives thereto.
  • The Board has only received a non-binding proposal, which does not constitute an offer or proposal capable of acceptance and may be withdrawn at any time and in any manner.
  • The Board resolutions establishing the Special Committee expressly provide that the Board will not approve the proposed transaction contemplated by the Expression of Interest or any alternative thereto without a prior favorable recommendation by the Special Committee.

Kontrol Retains Emerging Markets Consulting LLC for Investor Relations Advisory Services

Retrieved on: 
Thursday, December 31, 2020

This news release contains forward-looking information within the meaning of applicable securities laws.

Key Points: 
  • This news release contains forward-looking information within the meaning of applicable securities laws.
  • All statements contained herein that are not clearly historical in nature may constitute forward-looking information.
  • Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.
  • Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

Genprex, Inc. Announces $12 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules, Without Warrants

Retrieved on: 
Tuesday, December 22, 2020

The closing of the offering is expected to occur on or about December 24, 2020, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about December 24, 2020, subject to the satisfaction of customary closing conditions.
  • A.G.P./Alliance Global Partners is acting as sole placement agent for the offering.
  • This offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No.
  • Genprex undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Retrieved on: 
Wednesday, December 16, 2020

The closing of the offering is expected to occur on or about December 18, 2020, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about December 18, 2020, subject to the satisfaction of customary closing conditions.
  • A.G.P./Alliance Global Partners is acting as sole placement agent for the offering.
  • This offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No.
  • BioCardia undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Form 8.3 - Future Plc

Retrieved on: 
Tuesday, December 15, 2020

All interests and all short positions should be disclosed.

Key Points: 
  • All interests and all short positions should be disclosed.
  • Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
  • Class of relevant security in relation to which subscription right exists:
    Details, including nature of the rights concerned and relevant percentages:
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules [Revised]

Retrieved on: 
Tuesday, December 15, 2020

The closing of the offering is expected to occur on or about December 16, 2020, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about December 16, 2020, subject to the satisfaction of customary closing conditions.
  • A.G.P./Alliance Global Partners is acting as sole placement agent for the offering.
  • This offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No.
  • BioCardia undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Retrieved on: 
Monday, December 14, 2020

The closing of the offering is expected to occur on or about December 16, 2020, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about December 16, 2020, subject to the satisfaction of customary closing conditions.
  • A.G.P./Alliance Global Partners is acting as sole placement agent for the offering.
  • This offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No.
  • BioCardia undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.